Explore Based Update and more!

Explore related topics

anti-LINGO-1, one of the first drug medications to attempt to stimulate remyelination in patients suffering from multiple sclerosis (MS).  While the research is still in its early stages whould the phase 2 trial meet or exceed expectations a larger scale phase 3 trial will more than likely take place to confirm efficacy and safety of the treatment for people afflicted with multiple sclerosis.

anti-LINGO-1, one of the first drug medications to attempt to stimulate remyelination in patients suffering from multiple sclerosis (MS). While the research is still in its early stages whould the phase 2 trial meet or exceed expectations a larger scale phase 3 trial will more than likely take place to confirm efficacy and safety of the treatment for people afflicted with multiple sclerosis.

ZINBRYTA (Daclizumab) Gets Recommendation From European Medicines Agency Towards Market Authorization

ZINBRYTA (Daclizumab) Gets Recommendation From European Medicines Agency Towards Market Authorization

Kessler Foundation is a public charity dedicated to improving the lives of people with physical and cognitive disabilities caused by stroke, multiple sclerosis, injuries to the brain and spinal cord, and other chronic conditions.

Kessler Foundation is a public charity dedicated to improving the lives of people with physical and cognitive disabilities caused by stroke, multiple sclerosis, injuries to the brain and spinal cord, and other chronic conditions.

Multiple Sclerosis Association Of America Launches March MS Awareness Month The Multiple Sclerosis ...

Multiple Sclerosis Association Of America Launches March MS Awareness Month The Multiple Sclerosis ...

Pinterest
Search